Fix Price of Stents by March 1, Delhi High Court Directs Central Government

People in all age groups in the country suffer from heart ailments, requiring use of stents and not all of them can afford this treatment.

The Delhi High Court directed the central government to fix the maximum retail price (MRP) and a ceiling price by March 1, 2017, for coronary stents, used to treat narrowed or weakened arteries in patients.

The order, passed by a division bench of Chief Justice G. Rohini and Justice Sangita Dhingra Sehgal, came a day after coronary stent was notified by the Department of Pharmaceuticals (DoP) as a Schedule-I drug under the Drug Price Control Order (DPCO) 2013, making it eligible for price control.

Novel Dimension to the Assessment of New-Generation Drug-Eluting Stents
Bioresorbable polymer-based drug-eluting stents (BP-EES) are comparable to durable polymer-based drug-eluting stents (DP-ZES).

‘People in all age groups in the country suffer from heart ailments, requiring use of stents and not all of them can afford this treatment.’

This means that the National Pharmaceutical Pricing Authority (NPPA) can now start the process of fixing ceiling prices for a variety of stents.

On July 19 this year, the Health Ministry included stents in the National List of Essential Medicines (NLEM) after the court demanded action on a public interest petition filed by advocate Birender Sangwan who sought price control on stents.

The petitioner alleged that the government and the NPPA are being "insensitive and irresponsible" towards the people by not taking any steps to fix the price of the medical device which is allegedly being sold at high price in the country.

Role Of Strut Sirolimus-Eluting Stents In Treating Chronic Total Occlussions
Hybrid sirolimus-eluting stents with biodegradable polymer did not improve angiographic outcomes compared to everolimus-eluting stents with durable polymer.

It had also claimed that people in all age groups in the country suffer from heart ailments, requiring use of stents and not all of them can afford this treatment.

Source-IANS

Plastic Stents may be Cost-Effective Alternative For Malignant Biliary Obstruction
In PBD, the placement of fully covered self-expandable metal stents (FCSEMSs) may provide better patency duration and a lower incidence of cholangitis.

The Benefit or Harm of Antibody-Coated Drug-Eluting Stents Remains Unclear
The benefit of treatment with antibody-coated drug-eluting stents (ABC-DES) versus drug-eluting stents without antibody coating (DES) is still unclear.